Specific Biologics Revenue and Competitors

Toronto, ON CAN

Location

$28.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Specific Biologics's estimated annual revenue is currently $1.6M per year.(i)
  • Specific Biologics's estimated revenue per employee is $77,500
  • Specific Biologics's total funding is $28.4M.

Employee Data

  • Specific Biologics has 20 Employees.(i)
  • Specific Biologics grew their employee count by 82% last year.

Specific Biologics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.7M9-72%$39.4MN/A
#2
$0.9M11-83%$23.8MN/A
#3
$87.6M5656%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$7.8M50-68%N/AN/A
#6
$13.5M8730%N/AN/A
#7
$17.8M115-6%N/AN/A
#8
$0.9M11-39%N/AN/A
#9
$13.6M88-20%$86MN/A
#10
$20M129-12%N/AN/A
Add Company

What Is Specific Biologics?

Specific Biologics' mission is to develop novel gene editing technologies to treat diseases at the genetic level in cells inside the body. We are actively developing a platform technology consisting of a dual-cleaving nuclease that can be safely delivered to cells for the treatment of various genetic diseases. This technology is designed to better exploit the cell's naturally occurring DNA repair pathways through enhanced repair or predictable deletions.

keywords:N/A

$28.4M

Total Funding

20

Number of Employees

$1.6M

Revenue (est)

82%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Specific Biologics News

2022-04-17 - 10 Questions to Ask Your Doctor About Biologics for Psoriasis

Biologics are injectable medications that block a specific part of your immune system to help slow overactive skin cell production, dampen...

2022-04-06 - A Guide to Biologic Treatments for Eczema (Atopic Dermatitis)

Biologics for eczema target specific proteins in the body, which can help reduce overactivity in the immune system and calm eczema symptoms.

2022-04-06 - Retinal Biologics Market is Anticipated to Reach a Value of US ...

... Growing application of specific biologic molecules as a promising drug target; Development of gene therapy as retinal biologics in the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M205%N/A
#2
$1.3M20-5%N/A
#3
$2.7M20-17%N/A
#4
$2.1M20-20%N/A
#5
$2M20N/AN/A